Ever since Pfizer came up with its miracle blue pill in 1998, the pharmaceutical industry has been seeking a “female Viagra” as a holy grail. That quest has run into a number of obstacles, a major one being that while male arousal can be measured with a ruler, female arousal is much more difficult to gauge. That idea